Intas Pharmaceuticals has a total of 571 patents globally, out of which 146 have been granted. Of these 571 patents, more than 77% patents are active. India is where Intas Pharmaceuticals has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, India seems to be the main focused R&D centre and also is the origin country of Intas Pharmaceuticals.
Intas Pharmaceuticals was founded in 1977. Intas Pharmaceuticals is a global pharmaceutical company offering biopharmaceutical products and services. They specialize in oncology products for solid tumors, blood cancers, and supportive therapies, as well as treatments for critical disorders. Their success and growth over three decades are due to strategic moves in manufacturing, R&D, biotechnology, and global operations.
Do read about some of the most popular patents of Intas Pharmaceuticals which have been covered by us in this article and also you can find Intas Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Intas Pharmaceuticals patent portfolio.
How many patents does Intas Pharmaceuticals have?
Intas Pharmaceuticals has a total of 571 patents globally. These patents belong to 174 unique patent families. Out of 571 patents, 250 patents are active.
How Many Patents did Intas Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Intas Pharmaceuticals Applications Filed | Intas Pharmaceuticals Patents Granted |
| 2024 | – | 6 |
| 2023 | 6 | 20 |
| 2022 | 45 | 15 |
| 2021 | 22 | 15 |
| 2020 | 89 | 21 |
| 2019 | 34 | 18 |
| 2018 | 41 | 9 |
| 2017 | 46 | 5 |
| 2016 | 26 | 10 |
| 2015 | 44 | 2 |
| 2014 | 61 | 2 |
How many Intas Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Intas Pharmaceuticals File in Different Countries?
Countries in which Intas Pharmaceuticals Filed Patents
| Country | Patent |
| India | 155 |
| United States of America | 52 |
| Europe (EPO) | 51 |
| Canada | 33 |
| Australia | 17 |
| Mexico | 16 |
| Germany | 16 |
| Brazil | 15 |
| Austria | 15 |
| Spain | 12 |
| South Africa | 12 |
| New Zealand | 10 |
| Japan | 9 |
| China | 6 |
| Russian Federation | 5 |
| Chile | 5 |
| Portugal | 4 |
| Poland | 4 |
| Italy | 4 |
| Singapore | 4 |
| Denmark | 3 |
| Malaysia | 3 |
| Israel | 3 |
| Philippines | 3 |
| United Kingdom | 3 |
| Indonesia | 3 |
| Malta | 2 |
| Hong Kong (S.A.R.) | 2 |
| Slovakia | 2 |
| Viet Nam | 2 |
| Colombia | 2 |
| Serbia | 2 |
| Korea (South) | 2 |
| Norway | 2 |
| Argentina | 2 |
| Uruguay | 1 |
| Croatia | 1 |
| Turkey | 1 |
| Hungary | 1 |
| Slovenia | 1 |
| Taiwan | 1 |
| Cyprus | 1 |
| Thailand | 1 |
| Lithuania | 1 |
Where are Research Centers of Intas Pharmaceuticals Patents Located?
10 Best Intas Pharmaceuticals Patents
WO2011141926A2 is the most popular patent in the Intas Pharmaceuticals portfolio. It has received 155 citations so far from companies like Coherus Biosciences, LG Life Sciences, Amgen.
Below is the list of 10 most cited patents of Intas Pharmaceuticals:
| Publication Number | Citation Count |
| WO2011141926A2 | 155 |
| WO2011004395A1 | 42 |
| WO2015151115A1 | 32 |
| US6710195B2 | 17 |
| WO2015095651A1 | 13 |
| WO2014102814A1 | 12 |
| WO2014118807A1 | 11 |
| US20090275647A1 | 9 |
| WO2015198257A1 | 9 |
| US20110177137A1 | 8 |
What are Intas Pharmaceuticals key innovation segments?
What Technologies are Covered by Intas Pharmaceuticals?
The chart below distributes patents filed by Intas Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Intas Pharmaceuticals thinks it’s important to protect particular technology inventions.
R&D Focus: How has Intas Pharmaceuticals search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!